Health

Hope for Boy with Rare Skin Condition: New Treatment Breakthrough

Hope for Young Patient with Rare Skin Condition Following Groundbreaking Trial A 12-year-old boy from East London, Gabrielius Misurenkovas, who suffers from a rare and debilitating skin condition, has experienced a glimmer of hope after participating in a pioneering clinical trial. Gabrielius was diagnosed with recessive dystrophic epidermolysis bullosa (RDEB), an inflammatory genetic disorder, in […]
  • maskobus
  • Aug 18, 2025
Health

P3 Health Partners outlines $120M–$170M EBITDA improvement opportunity for 2026 while strengthening payer contracts

Earnings Call Insights: P3 Health Partners Inc. (PIII) Q2 2025 Management View CEO Aric Coffman reported that the company is nearing full execution on its $130 million EBITDA improvement plan, stating, “Our core business is moving in a positive direction. And we are well positioned for continued momentum into 2026.” He highlighted that three out […]
  • maskobus
  • Aug 17, 2025
Health

Co-Diagnostics outlines clinical trial timeline and targets mid-2026 commercialization for PCR platform

Earnings Call Insights: Co-Diagnostics, Inc. (CODX) Q2 2025 Management View CEO Dwight H. Egan reported continued progress on the Co-DX PCR point-of-care platform, stating, “We remain on track to initiate clinical evaluations for all tests in our pipeline during 2025.” Egan highlighted imminent clinical evaluations for the COVID-19 test and noted additional pipeline tests including […]
  • maskobus
  • Aug 16, 2025